Metabolic Abnormalities Caused by 3-Acetylpyridine in the Cerebral Motor Regions of Rats: Partial Recovery by Thyrotropin-Releasing Hormone
スポンサーリンク
概要
- 論文の詳細を見る
Although 3-acetylpyridine(3-AP) induces several motor disturbances and it degenerates the olivocerebellar pathway, abnormalities caused by 3-AP in cerebral motor regions remain to be elucidated.Here we investigated the metabolic changes caused by 3-AP(75mg/kg, i.p.) on local cerebral glucose utilization(LCGU) in various brain regions.The effects of anti-ataxic agents, thyrotropin-releasing hormone(TRH)(10mg/kg, i.p.) and its mimetic agent taltirelin hydrate(1mg/kg, i.p.), on the 3-AP-induced change in LCGU were also investigated.The LCGU in the nuclei of the basal ganglia, thalamus, limbic structures and brainstem of 3-AP-treated rats was significantly lower than that of naive animals.However 3-AP increased the LCGU of the cerebellar nuclei.TRH restored depressed LCGU in the substantia nigra and ventral tegmental area.TRH tended to restore the lowered LCGU in several nuclei of 3-AP-treated rats.Moreover, taltirelin further increased the LCGU in the cerebellar nuclei.These results suggest that the motor disturbance of the 3-AP-treated rats may be due to not only degeneration of the olivocerebellar pathway but also dysfunction of the several areas that play a role in motor coordination.Moreover, the anti-ataxic action by TRH could result from metabolic restoration of the multiple motor-coordination-related areas.
- 社団法人 日本薬理学会の論文
- 2000-04-01
著者
-
Watanabe Yumi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
ASAI Hidetoshi
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
Watanabe Y
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Matsuoka Yuzo
Discovery Researchlaboratory Tanabe Seiyaku Co. Ltd.
-
Matsuoka Yuzo
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Asai Hidetoshi
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Asai Hidetoshi
Pharmaceutical Development Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Kawashima K
Nagoya Inst. Of Technol. Nagoya Jpn
-
Yamamura Michio
Tanabe R&d Service Co. Ltd.
-
KINOSHITA Kiyoshi
Pharmacology Department, Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Yamamura Michio
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Kinoshita Kiyoshi
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Watanabe Yumi
Pharmacology Department, Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
関連論文
- Long-Lasting Anti-emetic Effect of T-2328, a Novel NK_1 Antagonist
- Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK_1 Receptor
- Possible Therapeutic Effect of T-794,a Novel Reversible Inhibitor of Monoamine Oxidase-A, on Post-Stroke Emotional Disturbances, Assessed in Animal Models of Depression
- Stereoselective Pharmacokinetics of RS-8359,A Selective and Reversible Inhibitor of A-Type Monoamine Oxidase, in Rats, Mice, Dogs, and Monkeys
- Quantitative determination of diol metabolites of CS-670, a new antiinflammatory agent, by capillary column gas chromatography-mass spectrometry
- Ultrasonic Measurement of Axial Stress in Short Bolts with Consideration of Nonlinear Deformation
- L-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- Enhancement of the Serotonin-Mediated Acetylcholine Release by Repeated Desmethylimipramine Treatment in the Hippocampus of Freely Moving Rats
- Protective Effect of Fluvastatin on Degradation of Apolipoprotein B by a Radical Reaction in Human Plasma
- Metabolic Abnormalities Caused by 3-Acetylpyridine in the Cerebral Motor Regions of Rats: Partial Recovery by Thyrotropin-Releasing Hormone
- Diversity of Thyrotropin-Releasing Hormone Receptors in the Pituitaryand Discrete Brain Regions of Rats
- Distribution of Thyrotropin-Releasing Hormone (TRH) Receptors in the Brain of the Ataxic Mutant Mouse, Rolling Mouse Nagoya
- Chronic Anti-ataxic Actions of the Novel Thyrotropin-Releasing Hormone (TRH) Analog, TA-0910,during and after Repeated Administration in Rolling Mouse Nagoya : Behavioral and Pharmacokinetic Studies
- Effect of TA-0910, a Novel Thyrotropin-Releasing Hormone Analog, on In Vivo Acetylcholine Release and Turnover in Rat Brain
- Antihypertensive Effect of Chronic KT3 - 671, a Structurally New Nonpeptide Angiotensin AT_1 - Receptor Antagonist, in Stroke - Prone Spontaneously Hypertensive Rats
- Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin_ receptor agonist, in normal and ρ-chlorophenylalanine-treated rats as measured by in vivo microdialysis
- Antihypertensive Effect of Repeatedly Administered YM358, an Angiotensin AT_1-Receptor Antagonist, in Stroke-Prone Spontaneously Hypertensive Rats
- Application of Radioimmunoassay for Acetylcholine to Physiological and Pharmacological Studies
- IMPROVED SENSITIVITY OF RADIOIMMUNOASSAY FOR MELATONIN BY USING A TRITIATED COMPOUND OF A HIGH SPECIFIC ACTIVITY
- Anti-apoptotic Effect of Acetyl-l-carnitine and l-Carnitine in Primary Cultured Neurons
- Pharmacological Characterization of T-2328, 2-Fluoro-4-methoxy-3-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK1 Receptor
- Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system.
- A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative.
- Neurochemical study of mafoprazine, a new phenylpiperazine derivative.